anti-MED13L (MED13L) 抗体产品概述

Full name:
anti-Mediator Complex Subunit 13-Like 抗体 (MED13L)
在www.antibodies-online.cn可供13 Mediator Complex Subunit 13-Like (MED13L) 抗体的6不同的供货商。 再加上,我们可以发MED13L 试剂盒 (11)和数多这个蛋白质的别的产品。 总共26 MED13L产品已列进来了。
2210413I17Rik, 6330591G05Rik, 9030618F05Rik, mKIAA1025, PROSIT240, Thrap2, Trap240L
列出全部抗体 基因 基因ID UniProt
MED13L 23389 Q71F56
MED13L 76199 Q6JPI3
MED13L 360817  



最受欢迎的抗anti-MED13L (MED13L) 抗体


抗Human MED13L 抗体:

抗Mouse (Murine) MED13L 抗体:

抗Rat (Rattus) MED13L 抗体:

所有可销售的anti-MED13L 抗体


引用最多的anti-MED13L 抗体

  1. Human Polyclonal MED13L Primary Antibody for IHC, ELISA - ABIN1535015 : Muncke, Jung, Rüdiger, Ulmer, Roeth, Hubert, Goldmuntz, Driscoll, Goodship, Schön, Rappold: Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). in Circulation 2003 (PubMed)


Human Mediator Complex Subunit 13-Like (MED13L) interaction partners

  1. Two siblings exhibited an intragenic deletion involving exons 3-14, which led to an in-frame deletion in MED13L. The deletion was inherited from their carrier mother who possessed low frequency mosaicism. The older sister of the siblings showed craniosynostosis; this condition has never been reported in patients with MED13L haploinsufficiency syndrome

  2. Heterozygous MED13L variants cause transposition of the great arterie.

  3. Analysis of genomic data in connection with deep clinical evaluation of patients could elucidate genetic heterogeneity of the MED13L haploinsufficiency phenotype

  4. A meta-analysis of genome-wide association studies of blood pressure and hypertension in Chinese identified three new loci (CACNA1D (显示 CACNA1D 抗体), CYP21A2 (显示 CYP21A2 抗体), and MED13L) and a newly discovered variant near SLC4A7 (显示 SLC4A7 抗体).

  5. Impaired development of neural-crest cell-derived organs and intellectual disability caused by MED13L haploinsufficiency.

  6. Description of three patients with copy number changes affecting MED13L and delineation of a recognizable MED13L haploinsufficiency syndrome.

  7. We show that the Mediator complex subunit MED13L is required for Rb/E2F (显示 E2F1 抗体) control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition.

  8. PROSIT240 shows significant homology to the nuclear receptor coactivator TRAP240 (显示 MED13 抗体), suggesting it to be a new component of the thyroid hormone receptor (显示 THRA 抗体)-associated protein (显示 BCAP31 抗体) (TRAP) complex. PROSIT240 is involved in early heart and brain development.

Mouse (Murine) Mediator Complex Subunit 13-Like (MED13L) interaction partners

MED13L 抗原简介

Antigen Summary

The protein encoded by this gene is a subunit of the Mediator complex, a large complex of proteins that functions as a transcriptional coactivator for most RNA polymerase II-transcribed genes. The encoded protein is involved in early development of the heart and brain. Defects in this gene are a cause of transposition of the great arteries, dextro-looped (DTGA).

Alternative names and synonyms associated with MED13L

  • mediator complex subunit 13-like (MED13L) 抗体
  • mediator complex subunit 13-like (Med13l) 抗体
  • mediator of RNA polymerase II transcription subunit 13-like (LOC100739605) 抗体
  • 2210413I17Rik 抗体
  • 6330591G05Rik 抗体
  • 9030618F05Rik 抗体
  • mKIAA1025 抗体
  • PROSIT240 抗体
  • Thrap2 抗体
  • Trap240L 抗体

Protein level used designations for MED13L

mediator of RNA polymerase II transcription subunit 13-like , thyroid hormone receptor-associated protein 2 , thyroid hormone receptor-associated protein complex 240 kDa component-like , thyroid hormone receptor associated protein 2 , thyroid hormone receptor-associated 240-like protein

23389 Homo sapiens
76199 Mus musculus
360817 Rattus norvegicus
101108604 Ovis aries
100739605 Sus scrofa
anti-MED13L (MED13L) 抗体 精选生产商